BioSpace News Archive

The Focused Ultrasound Foundation has appointed two leading executives to its Board of Directors. Scott Beardsley, Dean of the University of Virginia Darden School of Business, and Mike Lincoln, Global Business Department Chair at the international law firm Cooley LLP, will lend their expertise in advancing the Foundation’s mission.

Novel BIV201 Formulation Shows Significant Improvements Over Industry Terlipressin Prefilled Syringe May Significantly Extend Market Protection Beyond Orphan Drug Exclusivity SANTA MONICA, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced today that following the company’s successful Phase 2a study, it has received guidance from the US Food and Drug Administ

Arch Biopartners Inc. announced that its Board of Directors has granted a total of 1,430,000 stock options to directors, officers and certain consultants pursuant to the Company’s stock option plan and the requirements of the TSX Venture Exchange.

Leverages Dario’s flexible AI-driven platform to facilitate rapid implementation and potential revenue in 2020 Centers for Medicare & Medicaid Services(CMS) recently approved RPM codes for Medicare patients enabling physicians to bill for between patient care which may result in improved patient outcomes and reduced long-term treatment costs RPM offering further supports Dario’s transition to high-margin, recurring SaaS model targeting B2B2C revenue channels

Antisense Therapeutics (ASX:ANP | US OTC:ATHJY), an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the Muscular Dystrophy Association (MDA) Virtual 2020 Conference website. For 70 years MDA has been committed to transforming the lives of people living with muscular dystrophy, ALS, and relate

ProTom International announces that it will install its Radiance 330® Proton Therapy System at the new Australian Bragg Centre, Adelaide, Australia.

Environmental Monitoring in manufacturing is a critical quality parameter during and post the COVID-19 Era. As the world plans to renew, rebuild, and expand their stockpiles, from vaccines to all critical medications required during this time, the demand has certainly increased.

Quanta, Inc. (OTCPK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual “Town Hall” style investor event, which will be broadcast live over the internet on June 15, 2020 at 1:30 PM ET / 10:30 AM PT. Eric Rice, the company’s Chief Executive Officer, will lead the session and provide updates on rece

Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, announced the promotion of Stuart Chaffee, Ph.D., to chief financial officer, effective immediately.

U.K. medical chart study showed an association between patients treated with terlipressin and an improvement in kidney function in 73 percent of hospitalized adult patients with HRS-1